Industries > Pharma > Generic Drugs Market Forecast 2019-2029

Generic Drugs Market Forecast 2019-2029

Growth in Leading Regional and National Markets – North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico, Teva, Novartis, Mylan, Pfizer, Abbott, Sun Pharma, Aspen, Fresenius Kabi, Sanofi, Dr. Reddy’s Laboratories Limited, Apotex

PUBLISHED: 14 June 2019
PAGES: 246
PRODUCT CODE: PHA0438
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1

The generic drugs market is estimated to have reached $257.3bn in 2018 and is expected to grow at a CAGR of 8.8% in the first half of the forecast period. Asia-Pacific held 31% of the generic drugs market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 246-page report you will receive 66 tables and 84 figures– all unavailable elsewhere.

The 246-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Generic Drugs Market forecasts from 2019-2029

• Generic Drugs Market forecasts from 2019-2029 by Regional and National Market:
• North America: U.S., Canada
• Europe: Germany, France, UK, Italy, Spain, Rest of Europe
• Asia-Pacific: Japan, China, Australia, South Korea, India, Rest of Asia-Pacific
• Middle East & Africa: South Africa, Saudi Arabia, UAE, Rest of Middle east & Africa
• Latin America: Brazil, Argentina, Mexico, Rest of Latin America

Generic Drugs Market Forecast 2019-2029

• Profiles and generic drugs revenue forecasts from 2019-2029 of these selected leading companies:
• Abbott
• Apotex
• Aspen
• Dr. Reddy’s Laboratories Limited
• Fresenius Kabi
• Mylan
• Novartis
• Pfizer
• Sanofi
• Sun Pharma
• Teva

• Qualitative analysis of the generic drugs market:
SWOT Analysis of the generic drugs market
Porter’s Five Forces Analysis of the generic drugs market
• Discussion on factors that drive and restrain the generic drugs market

• Key Questions Answered by This Report:
• How is the global market for generic drugs evolving?
• What are the major factors driving and restraining the generic drugs market dynamics?
• What were the market shares of the leading national markets in the global generic drugs market in 2018?
• How will each of these national markets grow over the forecast period and how much revenue will these markets account for by 2029?
• How will the market shares for each of the national markets develop from 2018 to 2029?
• Which particular national markets will be the main drivers of growth in the global market for generics from 2018 to 2029?
• How will political and regulatory factors influence the regional markets and submarkets?
• What are the predictions for partnerships, consolidation for existing players and the potential prospects for new market entrants?
• How will the industry sector evolve as legislations around patents and patent expiries change during the period between 2018 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the Generic Drugs Market. You find data, trends and predictions.

Buy our report today Global Generic Drugs Market Analysis : Forecast From 2019-2029 Growth in Leading Regional and National Markets – North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico, Teva, Novartis, Mylan, Pfizer, Abbott, Sun Pharma, Aspen, Fresenius Kabi, Sanofi, Dr. Reddy’s Laboratories Limited, Apotex.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Generic Drugs Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Generic Drugs Market Forecast 2019-2029


Latest Pharma news

Visiongain Publishes 3D Bioprinting Market Report to 2031

In recent years, there are major technological innovations that have taken place in the 3D bioprinting industry for numerous medical applications, including cancer drugs, bone and cartilage development, skin tissue development, and liver modeling.

09 March 2021

READ

Visiongain Publishes Rare Diseases Market Report 2021-2031

As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.

02 March 2021

READ

Visiongain Publishes Respiratory Inhalers Market Report 2021-2031

Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.

26 February 2021

READ

Visiongain Publishes Bile Duct Cancer Drugs Market Report to 2031

The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.

22 February 2021

READ

Categories